5//SEC Filing
Jones Edward Raymond 5
Accession 0001144204-19-008362
CIK 0001175151other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 5:20 PM ET
Size
11.4 KB
Accession
0001144204-19-008362
Insider Transaction Report
Form 5
Jones Edward Raymond
Director
Transactions
- Exercise/Conversion
Common Stock
2018-05-31$0.88/sh+1,800$1,575→ 73,600 total - Exercise/Conversion
Common Stock
2018-08-14$2.00/sh+1,200$2,400→ 74,800 total - Exercise/Conversion
Stock Option (right to buy)
2018-05-31−1,800→ 0 totalExercise: $0.88From: 2008-06-25Exp: 2018-06-25→ Common Stock (1,800 underlying) - Exercise/Conversion
Stock Option (right to buy)
2018-08-14−1,200→ 0 totalExercise: $2.00From: 2008-12-31Exp: 2018-12-31→ Common Stock (1,200 underlying)
Footnotes (1)
- [F1]Includes (a) the following restricted stock units subject to vesting upon a "Change in Control" of CytoSorbents Corporation, as defined in the CytoSorbents Corporation 2014 Long-Term Incentive Plan: (i) 3,300 restricted stock units granted on March 15, 2018, (ii) 6,000 restricted stock units granted on February 24, 2017, (iii) 5,000 restricted stock units granted on June 7, 2016, and (iv) 55,000 restricted stock units granted on April 8, 2015, and (b) 5,500 shares of common stock owned by the reporting person.
Documents
Issuer
Cytosorbents Corp
CIK 0001175151
Entity typeother
Related Parties
1- filerCIK 0001396246
Filing Metadata
- Form type
- 5
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 5:20 PM ET
- Size
- 11.4 KB